Attached files

file filename
EX-32.2 - EX-32.2 - IDERA PHARMACEUTICALS, INC.idra-20201231xex32d2.htm
EX-32.1 - EX-32.1 - IDERA PHARMACEUTICALS, INC.idra-20201231xex32d1.htm
EX-31.2 - EX-31.2 - IDERA PHARMACEUTICALS, INC.idra-20201231xex31d2.htm
EX-31.1 - EX-31.1 - IDERA PHARMACEUTICALS, INC.idra-20201231xex31d1.htm
EX-10.26 - EX-10.26 - IDERA PHARMACEUTICALS, INC.idra-20201231xex10d26.htm
EX-10.25 - EX-10.25 - IDERA PHARMACEUTICALS, INC.idra-20201231xex10d25.htm
EX-4.21 - EX-4.21 - IDERA PHARMACEUTICALS, INC.idra-20201231xex4d21.htm
10-K - 10-K - IDERA PHARMACEUTICALS, INC.idra-20201231x10k.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1)Registration Statement (Form S-8 No. 333-152669) pertaining to the 2008 Stock Incentive Plan of Idera Pharmaceuticals, Inc.
(2)Registration Statement (Form S-8 No. 333-176067) pertaining to the 2008 Stock Incentive Plan and 1995 Employee Stock Purchase Plan of Idera Pharmaceuticals, Inc.
(3)Registration Statement (Form S-8 No. 333-191076) pertaining to the 2013 Stock Incentive Plan of Idera Pharmaceuticals, Inc.
(4)Registration Statement (Form S-8 No. 333-197062) pertaining to the 2013 Stock Incentive Plan of Idera Pharmaceuticals, Inc.
(5)Registration Statement (Form S-8 No. 333-202691) pertaining to Inducement Stock Option Awards of Idera Pharmaceuticals, Inc.
(6)Registration Statement (Form S-8 No. 333-206129) pertaining to the 2013 Stock Incentive Plan, as amended, of Idera Pharmaceuticals, Inc.
(7)Registration Statement (Form S-8 No. 333-210090) pertaining to an Inducement Stock Option Award of Idera Pharmaceuticals, Inc.
(8)Registration Statement (Form S-1 as amended by Form S-3/A No. 333-136610) of Idera Pharmaceuticals, Inc.
(9)Registration Statement (Form S-1 as amended by Form S-3/A No. 333-187155) of Idera Pharmaceuticals, Inc.
(10)Registration Statement (Form S-2 as amended by Form S-3/A No. 333-109630) of Idera Pharmaceuticals, Inc.
(11)Registration Statement (Form S-3 No. 333-119943) of Idera Pharmaceuticals, Inc.
(12)Registration Statement (Form S-3 No. 333-126634) of Idera Pharmaceuticals, Inc.
(13)Registration Statement (Form S-3 No. 333-131804) of Idera Pharmaceuticals, Inc.
(14)Registration Statement (Form S-3 No. 333-133455) of Idera Pharmaceuticals, Inc.
(15)Registration Statement (Form S-3 No. 333-133456) of Idera Pharmaceuticals, Inc.
(16)Registration Statement (Form S-3 No. 333-139830) of Idera Pharmaceuticals, Inc.
(17)Registration Statement (Form S-3 as amended by Form S-3/A No. 333-185392) of Idera Pharmaceuticals, Inc.
(18)Registration Statement (Form S-3 No. 333-186312) of Idera Pharmaceuticals, Inc.
(19)Registration Statement (Form S-3 No. 333-189700) of Idera Pharmaceuticals, Inc.
(20)Registration Statement (Form S-3 No. 333-191073) of Idera Pharmaceuticals, Inc.
(21)Registration Statement (Form S-3 No. 333-210140) of Idera Pharmaceuticals, Inc.
(22)Registration Statement (Form S-8 No. 333-217665) pertaining to an Inducement Stock Option Award of Idera Pharmaceuticals, Inc.
(23)Registration Statement (Form S-8 No. 333-219740) pertaining to the 2017 Employee Stock Purchase Plan of Idera Pharmaceuticals, Inc.
(24)Registration Statement (Form S-8 No. 333-219741) pertaining to the 2013 Stock Incentive Plan, as amended, of Idera Pharmaceuticals, Inc.
(25)Registration Statement (Form S-8 No. 333-232609) pertaining to the 2017 Employee Stock Purchase Plan of Idera Pharmaceuticals, Inc.

(26)Registration Statement (Form S-8 No. 333-232610) pertaining to the 2013 Stock Incentive Plan, as amended, of Idera Pharmaceuticals, Inc.
(27)Registration Statement (Form S-3 No. 333-238868) of Idera Pharmaceuticals, Inc.
(28)Registration Statement (Form S-3 No. 333-240361) of Idera Pharmaceuticals, Inc.
(29)Registration Statement (Form S-3 No. 333-240366) of Idera Pharmaceuticals, Inc.
(30)Registration Statement (Form S-3 No. 333-248560) of Idera Pharmaceuticals, Inc.

of our report dated March 1, 2021, with respect to the financial statements of Idera Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Idera Pharmaceuticals, Inc. for the year ended December 31, 2020.

/s/ ERSNT & YOUNG LLP

Philadelphia, Pennsylvania

March 1, 2021